Assignee
SCIDOSE LLC
US·6 granted patents·5 pending applications·56 citations·filing 2008–2019
Top patents by PatentIndex Score
11 records- 0197US7772274B1Docetaxel formulations with lipoic acidSCIDOSE LLC·Filed 2010·Granted Aug 10, 2010·41 cites·20 claims
- 0293US10376559B2Formulations of vancomycinSCIDOSE LLC·Filed 2017·Granted Aug 13, 2019·5 cites·16 claims
- 0391US10864250B2Formulations of vancomycinSCIDOSE LLC·Filed 2019·Granted Dec 15, 2020·3 cites·14 claims
- 0488US9616098B2Formulations of vancomycinSCIDOSE LLC·Filed 2014·Granted Apr 11, 2017·4 cites·19 claims
- 0586US8809308B2Enema composition for treatment of ulcerative colitis having long term stabilitySCIDOSE LLC·Filed 2013·Granted Aug 19, 2014·3 cites·29 claims
- 0669US9238037B2Enema composition for treatment of ulcerative colitis having long term stabilitySCIDOSE LLC·Filed 2014·Granted Jan 19, 2016·0 cites·21 claims
- 0769US2008319048A1Solubilized formulation of docetaxel without tween 80SCIDOSE LLC·Filed 2008·Application pending·0 cites
- 0864US2011092579A1Solubilized formulation of docetaxelSCIDOSE LLC·Filed 2009·Application pending·0 cites
- 0956US2017202906A1Formulations of vancomycinSCIDOSE LLC·Filed 2017·Application pending·0 cites
- 1049US2010234443A1Combinations of statins and anti-obesity agentSCIDOSE LLC·Filed 2010·Application pending·0 cites
- 1147US2010239669A1Combinations of statins and anti-obesity agentSCIDOSE LLC·Filed 2010·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →